Development and Validation of an HPLC–MS/MS Method for Pioglitazone from Nanocarriers Quantitation in Ex Vivo and In Vivo Ocular Tissues †

Pioglitazone (PGZ) is an oral anti-hyperglycemic agent, belongs to the class of thiazolidinediones, and is used for the treatment of diabetes mellitus type 2. In recent years, its anti-inflammatory activity has also been demonstrated in the literature for different diseases, including ocular inflamm...

Descripción completa

Detalles Bibliográficos
Autores principales: Miralles-Cardiel, Esther, Silva-Abreu, Marcelle, Calpena, Ana Cristina, Casals, Isidre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147631/
https://www.ncbi.nlm.nih.gov/pubmed/34063615
http://dx.doi.org/10.3390/pharmaceutics13050650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147631/
https://www.ncbi.nlm.nih.gov/pubmed/34063615
http://dx.doi.org/10.3390/pharmaceutics13050650

Ejemplares similares